Top Markets
Coin of the day
Pharnext S.A. Pharnext S.A.

Pharnext S.A.

ALPHA
Clasificación en acciones #42432
Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm... Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm dedicated to creating treatments for a range of neurodegenerative disorders, encompassing both rare (orphan) and common forms. Its pipeline features SYNGILITY, which has advanced through Phase III trials for Charcot-Marie-Tooth disease type 1A (CMT1A). Additionally, PXT864 has concluded Phase II clinical studies for Alzheimer's disease, and is also being explored for its potential in Parkinson's disease and amyotrophic lateral sclerosis (ALS). Pharnext also innovates with PLEOTHERAPY, a proprietary platform that harnesses big genetic data and artificial intelligence. In a collaborative effort, the company holds an agreement with the University Hospital Institute Mediterranee Infection to assess existing pharmaceuticals for their potential application against the COVID-19 virus. The organization was established in 2007, with its main offices located in Issy-Les-Moulineaux, France.
Precio por acción
$0.00023723
Última sincronización: 2024-08-26
Capitalización bursátil
$1.41K
Cambio (1 día)
111.67%
Cambio (1 año)
0.00%
País
FR
Comercio Pharnext S.A. (ALPHA)

Categoría

Historial de dividendos de Pharnext S.A. (ALPHA)
Pharnext S.A. (símbolo bursátil: ALPHA) realizó un total de 1 pagos de dividendos.
La suma de todos los dividendos (ajustados por splits de acciones) es: $0.20
Rentabilidad por dividendo (TTM): 0
Pagos de dividendos de Pharnext S.A. (ALPHA) desde 2024 hasta 2026
Pagos anuales de dividendos
Año Dividendo (ajustado por splits de acciones) Cambiar
2026 (TTM) $0.2 0.00%
2024 $0.2 0.00%
Lista de todos los pagos de dividendos
Año Dividendo Cambiar
2026 (TTM) $0.2 0.00%
2024 $0.2 0.00%
Pagos de dividendos de empresas similares o competidoras
Empresa Número de pagos de dividendos País
0.00%
US
0.00%
NL
0.00%
CH
29.00%
BE
0.00%
KR